Kidney International 2011-03-01

Prevention of vascular calcification: is pyrophosphate therapy a solution?

Veerle P Persy, Marc D McKee

Index: Kidney Int. 79(5) , 490-3, (2011)

Full Text: HTML

Abstract

Pyrophosphate, a ubiquitous small-molecule inhibitor of mineralization abundantly present in the extracellular environment, binds to calcium and mineral surfaces to inhibit crystal growth. O'Neill and colleagues show in uremic rats that systemic administration of pyrophosphate prevents or reduces uremia-related vascular calcification, without overt negative consequences for bone and without calcium pyrophosphate deposition disease. These findings prompt further research into the potential of pyrophosphate as treatment for vascular calcification in chronic kidney disease patients.

Related Compounds

Structure Name/CAS No. Articles
Disodium dihydrogen diphosphate Structure Disodium dihydrogen diphosphate
CAS:7758-16-9
Sodium diphosphate hydrate (4:1:10) Structure Sodium diphosphate hydrate (4:1:10)
CAS:13472-36-1
Tetrasodium pyrophosphate Structure Tetrasodium pyrophosphate
CAS:7722-88-5